The Medicines Company was a pharmaceutical firm focused on advancing the treatment of critical care patients through innovative, cost-effective medicines. It was known for its primary commercial product, Angiomax, and was involved in the development of investigational cholesterol-lowering therapies. The company was acquired by Novartis in 2020.
Focus Areas
Notable Investments
